Back to Search
MARKUS BOOS, M.D., PH.D.
M.D., PH.D.
Pediatric Dermatology Physician
NPI: 1225359680Individual
Specialties, Licenses & Credentials
Pediatric Dermatology PhysicianPrimary
Dermatology — Pediatric Dermatology
Code: 207NP0225X
MD450979(PA)
Research & Publications (20)
Post-hatching parental care behaviour and hormonal status in a precocial bird.
PMID 17600638·Behav Processes·2007
7-preclinical
Arterial first pass gadolinium-CM dynamics as a function of several intravenous saline flush and Gd volumes.
PMID 11276101·J Magn Reson Imaging·2001
8-other
Extrinsic and intrinsic regulation of early natural killer cell development.
PMID 18266115·Immunol Res·2008
6-review
"One-stop-shop" ultrasound diagnosis of functional, structural and physicomechanical properties of the brachial artery.
PMID 17708101·Vasa·2007
8-other
Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity.
PMID 17452521·J Exp Med·2007
4-observational
Preparation of hepatitis C virus structural and non-structural protein fragments and studies of their immunogenicity.
PMID 16889980·Protein Expr Purif·2006
7-preclinical
Recombinant virus-like particles as a carrier of B- and T-cell epitopes of hepatitis C virus (HCV).
PMID 16574285·Vaccine·2006
7-preclinical
Gender in medical ethics: re-examining the conceptual basis of empirical research.
PMID 12710564·Med Health Care Philos·2003
8-other
Unsubscribe, pleeezz!!!: management and training of media competence in computer-mediated communication.
PMID 12216697·Cyberpsychol Behav·2002
8-other
Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1.
PMID 12161037·J Neuroimmunol·2002
8-other
Characterization of clinical Streptococcus pneumoniae strains from Germany with decreased susceptibility to fluoroquinolones.
PMID 12039895·J Antimicrob Chemother·2002
4-observational
Production of BRO beta-lactamases and resistance to complement in European Moraxella catarrhalis isolates.
PMID 11923393·J Clin Microbiol·2002
8-other
In vitro activity of the novel des-F(6) quinolone BMS-284756 against genetically characterized clinical streptococcal isolates, including isolates with reduced quinolone susceptibility.
PMID 11909849·J Antimicrob Chemother·2002
8-other
In vitro activities of novel des-fluoro(6) quinolone BMS-284756 against mutants of Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus selected with different quinolones.
PMID 11850293·Antimicrob Agents Chemother·2002
4-observational
Increased in vitro activity of the novel des-fluoro(6) quinolone BMS-284756 against genetically defined clinical isolates of Staphylococcus aureus.
PMID 11815569·J Antimicrob Chemother·2002
4-observational
In vitro activity of faropenem and 20 other compounds against beta-lactamase-positive and -negative Moraxella catarrhalis and Haemophilus influenzae isolates and the effect of serum on faropenem MICs.
PMID 11751796·J Antimicrob Chemother·2002
4-observational
Induction of in vitro resistance to BMS-284756 by Streptococcus pneumoniae.
PMID 11581245·J Antimicrob Chemother·2001
8-other
Propensity of fluoroquinolones with different moieties at position 8 to cause resistance development in clinical isolates of Streptococcus pneumoniae.
PMID 11523528·Antimicrob Agents Chemother·2001
8-other
In vitro activity of faropenem and 21 other compounds against 385 different genetically characterized isolates of antibiotic-resistant Streptococcus pneumoniae.
PMID 11418531·J Antimicrob Chemother·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3535 MARKET ST, DIVISION OF DERMATOLOGY, 2ND FLOOR
PHILADELPHIA, PA 19104 - Phone
- (248) 506-7354
Quick Facts
- NPI
- 1225359680
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile